ERBB2 and breast cancer: Current therapy approaches for BC are roughly customized in response to a handful of molecular profiles (luminal, basal-like, and human epidermal growth factor receptor-2 positive) and consists of chemotherapy, endocrine therapy, selective estrogen receptor modulators, and targeted therapies [3].